A citation-based method for searching scientific literature

M William Audeh, James Carmichael, Richard T Penson, Michael Friedlander, Bethan Powell, Katherine M Bell-McGuinn, Clare Scott, Jeffrey N Weitzel, Ana Oaknin, Niklas Loman, Karen Lu, Rita K Schmutzler, Ursula Matulonis, Mark Wickens, Andrew Tutt. Lancet 2010
Times Cited: 977



Joyce F Liu, William T Barry, Michael Birrer, Jung-Min Lee, Ronald J Buckanovich, Gini F Fleming, Bj Rimel, Mary K Buss, Sreenivasa Nattam, Jean Hurteau, Weixiu Luo, Philippa Quy, Christin Whalen, Lisa Obermayer, Hang Lee, Eric P Winer, Elise C Kohn, S Percy Ivy, Ursula A Matulonis. Lancet Oncol 2014
Times Cited: 389




List of shared articles



Times cited

Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma.
Arun Kanakkanthara, Xiaonan Hou, Thomas L Ekstrom, Valentina Zanfagnin, Amelia M Huehls, Rebecca L Kelly, Husheng Ding, Melissa C Larson, George Vasmatzis, Ann L Oberg,[...]. Cancer Res 2022
0


Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.
Abigail Tattersall, Neil Ryan, Alison J Wiggans, Ewelina Rogozińska, Jo Morrison. Cochrane Database Syst Rev 2022
0

PARP inhibitors in ovarian cancer: An overview of the practice-changing trials.
Tiffany Foo, Angela George, Susana Banerjee. Genes Chromosomes Cancer 2021
16

Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer.
Virginie Mieulet, Camille Garnier, Yann Kieffer, Thomas Guilbert, Fariba Nemati, Elisabetta Marangoni, Gilles Renault, Foucauld Chamming's, Anne Vincent-Salomon, Fatima Mechta-Grigoriou. Sci Rep 2021
12

Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis.
Francesco Schettini, Fabiola Giudici, Ottavia Bernocchi, Marianna Sirico, Silvia P Corona, Mario Giuliano, Mariavittoria Locci, Ida Paris, Giovanni Scambia, Sabino De Placido,[...]. Eur J Cancer 2021
14

PARP inhibitors: a tsunami of indications in different malignancies.
Gaëlle Haddad, Marie Christelle Saadé, Roland Eid, Fady Gh Haddad, Hampig Raphael Kourie. Pharmacogenomics 2020
7